Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
STING agonist
GnRH analog; GnRH1 agonist.
HDAC inhibitor. May reduce blood pressure in hy...
Primarily targets HDAC1
ACE inhibitor.
Imidazoquinazoline; PDE3 inhibitor.
Triazole; 14α demethylase inhibitor.
L-type Ca2+ channel blocker.
SIRT inhibitor.
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...
Steroid 5-α-reductase inhibitor.
Tropane alkaloid found in plants in the Solanac...
Synthetic prednisolone prodrug; glucocorticoid ...
Endogenous peptide hormone, GLP-1 fragment, inv...
Walrycin response regulator inhibitor.
HDAC inhibitor, mammalian RNA splicing modulato...
Thiol prodrug, antioxidant.
α7 nAChR partial agonist, 5-HT3 antagonist.
Tetracycline; protein translation inhibitor, MM...
STING inhibitor